Apac Point Care Testing Poct Market
Tamanho do mercado em biliões de dólares
CAGR : %
Período de previsão |
2022 –2029 |
Tamanho do mercado (ano base ) | USD 29.00 Billion |
Tamanho do mercado ( Ano de previsão) | USD 64.46 Billion |
CAGR |
|
Principais participantes do mercado |
|
>Mercado Ásia-Pacífico de testes no local de atendimento (POCT) , por produto (produtos de monitorização de glicose, produtos de testes cardiometabólicos , produtos de testes de doenças infecciosas, produtos de testes de gravidez e fertilidade, produtos de testes de marcadores de tumor /cancro, produtos de testes de urinálise, produtos de testes de colesterol , produtos para testes de hematologia, produtos para testes de drogas de abuso, produtos para testes ocultos nas fezes, testes de coagulação rápida e outros produtos POC), aplicação (transfusão de sangue, monitorização cardíaca, coagulação, glicemia, hematologia, monitorização de SPO2 não invasivo, não- Monitorização invasiva de PCO2, análise de sangue total, monitorização de sinais vitais e outros), plataforma (ensaios de fluxo lateral/testes de imunocromatografia, varetas, microfluídica, diagnóstico molecular e imunoensaios), modo de prescrição (testes baseados na prescrição e testes OTC), tipo de teste (imunoensaios , ensaios baseados em células, testes de amplificação de ácidos nucleicos, ensaios de química clínica e hematologia), utilizador final ( hospitais, clínicas, laboratórios, cuidados domiciliários, centros de cirurgia ambulatória e outros), canal de distribuição (concurso direto e farmácias de retalho) - tendências do setor e Previsão para 2029
Análise e dimensão do mercado
Testes no local de atendimento, que são definidos como testes que podem ser realizados nas proximidades do paciente e permitem que uma escolha médica seja feita imediatamente com base nos resultados e na monitorização . O teste no local de atendimento (POCT) , também conhecido como teste com paciente, permite aos médicos avaliar resultados de diagnóstico precisos em tempo real e com qualidade laboratorial em minutos, em vez de horas. Garante que os doentes recebem o atendimento mais eficaz e eficiente possível, quando e onde precisam.
A Data Bridge Market Research analisa que o mercado de testes no local de atendimento (POCT), que foi de 29 mil milhões de dólares em 2021, dispararia para 64,46 mil milhões de dólares até 2029 e deverá passar por um CAGR de 10,5% durante o período de previsão de 2022 até 2029. O relatório de mercado com curadoria da equipa de pesquisa de mercado da Data Bridge inclui análise especializada aprofundada, epidemiologia do paciente, análise de pipeline, análise de preços e estrutura regulamentar.
Definição de mercado
Os testes POC não são tão preferidos como os testes de laboratório central devido ao baixo volume e ao elevado custo. Isto coloca uma pressão adicional no sistema de faturação, que deve fornecer códigos distintos para os testes POC. Isto pode resultar em erros de faturação por parte de colaboradores inexperientes ou recém-contratados, bem como na falha na inserção de dados no sistema de gestão de dados devido a códigos de teste incompatíveis.
Âmbito do relatório e segmentação de mercado
Métrica de reporte |
Detalhes |
Período de previsão |
2022 a 2029 |
Ano base |
2021 |
Anos históricos |
2020 (personalizável para 2014 - 2019) |
Unidades Quantitativas |
Receita em biliões de dólares, volumes em unidades, preços em dólares |
Segmentos cobertos |
Product (Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Disease Testing Products, Pregnancy and Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Fecal Occult Testing Products, Rapid Coagulation Testing and Other POC Products), Application (Blood Transfusion, Cardiac Monitoring, Coagulation, Blood Glucose, Haematology, Non- Invasive SPO2 Monitoring, Non- Invasive PCO2 Monitoring, Whole Blood Analysis, Vital Sign Monitoring and Others), Platform (Lateral Flow Assays/Immunochromatography Tests, Dipsticks, Microfluidics, Molecular Diagnostics and Immunoassays), Prescription Mode (Prescription-Based Testing and OTC Testing), Testing Type (Immunoassays, Cell-Based Assays, Nucleic Acid Amplification Testing, Clinical Chemistry Assays and Hematology), End-User (Hospitals, Clinics, Laboratories, Home Care, Ambulatory Surgery Centers and Others), Distribution Channel (Direct Tender and Retail Pharmacies) |
Countries Covered |
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC) |
Market Players Covered |
Abbott (U.S), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S), Siemens Healthcare Private Limited (Germany), Bio-Rad Laboratories, Inc. (U.S), Danaher (U.S), Sekisui Diagnostics (U.S), Trinity Biotech (Ireland), bioMérieux (France), EKF Diagnostics (Germany), AccuBioTech Co., Ltd. (China), Instrumentation Laboratory (U.S), Beckman Coulter, Inc. (U.S), PTS Diagnostics (U.S), Nova Biomedical (U.S), Chembio Diagnostics, Inc. (U.S), Quidel Corporation (U.S) and Sienco, Inc (U.S) |
Market Opportunities |
|
Point-of-Care Testing (POCT) Market Dynamics
Drivers
- Upward trend in disease prevalence in the developing countries
Chronic diseases and acute infections are on the rise in developing countries, owing to a lack of health awareness, poor medical infrastructure, and a sedentary lifestyle, among other causes. As a result of these circumstances, diagnosis and treatment are delayed, as is the quality of care obtained. The need for point-of-care tests for rapid diagnosis is growing due to their convenience of use, cost-effectiveness, and small product size.
- Benefits related with OTC-based test
The point of care testing market for TC tests is expected to develop at a 7.1% CAGR through 2027, owing to an increase in OTC testing such as pregnancy tests and blood glucose tests that deliver results in a matter of seconds. These examinations do not necessitate the use of a skilled specialist and may be performed by individuals themselves, propelling the industry forward. The First Response kit, for example, is a quick pregnancy test that provides a response in 60 seconds. Accu-Chek active blood glucose metre kits also give customers with readings in 5 seconds, boosting market demand.
- Increasing incidence rate of diabetes and obesity lead to cardiovascular illness
The increased prevalence of diabetes and obesity, the point of care testing market for cardio metabolic testing is predicted to exceed USD 5.3 billion by 2027. The cardiometabolic test also determines the percentage level of Docosahexaenoic acid (DHA) and eicosapentanoic acid (EPA) in red blood cell membrane.This also aids in the identification of new risk factors for cardiac arrest and other heart-related disorders.
Opportunities
- Technological advancement in lateral flow assay
The market for lateral flow assays in point of care testing is expected to reach USD 11.8 billion by 2027. The industry's growth will be aided by the launch of novel products that will allow for rapid advancement in the research and development (R&D) of point-of-care testing (POCT) diagnostic tools. In addition, advances in component materials, reader technologies, reagents, and sensitivity increase have made quantitative results more possible with the use of lateral flow assay, supporting sector growth.
Restraints/Challenges
- Stringent regulatory policies
Due to tight and time-consuming regulatory requirements, the point of care testing industry is growing slowly. With the expanding area of use and increased adoption in developing economies, regulators are placing a greater emphasis on point-of-care testing (POCT) compliance, safety, and usability. Point-of-care testing are classed as class II medical devices by the US Food and Drug Administration. These devices provide a reasonable guarantee of the device's effectiveness and safety.
- Lack of alignment with definitive central lab methods
Unsuitable indications for the performance of the test, inappropriate sampling times and techniques, a lack of information about the patient's condition, and other factors such as fasting before functional tests or variations in posture/position during similar tests are all examples of pre-analytical errors for POC testing.
Este relatório de mercado de testes no ponto de atendimento (POCT) fornece detalhes de novos desenvolvimentos recentes, regulamentos comerciais, análise de importação-exportação, análise de produção, otimização da cadeia de valor, quota de mercado, impacto dos participantes do mercado nacionais e localizados, analisa as oportunidades em termos de bolsas de receitas emergentes, alterações nas regulamentações do mercado, análise estratégica do crescimento do mercado, tamanho do mercado, crescimento do mercado da categoria, nichos de aplicação e domínio, aprovações de produtos, lançamentos de produtos, expansões geográficas, inovações tecnológicas no mercado. Para mais informações sobre o mercado de testes no local de atendimento (POCT), contacte a Data Bridge Market Research para obter um resumo do analista, a nossa equipa irá ajudá-lo a tomar uma decisão de mercado informada para alcançar o crescimento do mercado .
Impacto do COVID-19 no mercado de testes no ponto de atendimento (POCT)
Com a crescente utilização de testes no local de atendimento que podem identificar rapidamente o COVID-19, o mercado de diagnóstico no local de atendimento aumentará significativamente em 2022. Os testes no local de atendimento tornaram-se uma importante técnica de diagnóstico devido à necessidade de rapidez resultados de diagnóstico. Os kits de teste rápido de antigénios que podem ser utilizados de forma eficiente nos locais de prestação de cuidados são muito procurados devido ao rápido aumento do número de casos de COVID-19 e à crescente pressão sobre os governos para melhorar a gestão dos doentes. Diferentes razões significativas concebidas para alimentar o crescimento a longo prazo do mercado de diagnóstico no local de atendimento são a crescente prevalência de outras doenças respiratórias em todo o mundo, a mudança para o diagnóstico descentralizado e o acesso melhorado a dispositivos no local de atendimento por meio on-line.
Desenvolvimento recente
A Roche introduziu o seu sistema Cobas Pulse em países selecionados que aceitaram a marca CE em janeiro de 2022. Esta é a última geração de soluções interligadas no local de prestação de cuidados para a gestão profissional da glicemia da Roche Diagnostics.
Em outubro de 2021, a Thermo Fisher Scientific anunciou que recebeu a Autorização de Utilização de Emergência (EUA) da FDA para executar testes COVID-19 com o dispositivo de recolha Spectrum Solutions SpectrumDNA SDNA-1000, um sistema de teste COVID-19 automatizado e de elevado rendimento no Amplitude Solução, utilizando um novo método de recolha de amostras de saliva.
O sistema SPECIFIC REVEAL Rapid AST foi distribuído co-exclusivamente na Europa pela bioMérieux e Specific Diagnostics em junho de 2021. O sistema funciona em conjunto com o BIOFIRE BCID2 da bioMérieux.
Âmbito do mercado de testes no local de atendimento (POCT) da Ásia-Pacífico
O mercado de testes no local de atendimento (POCT) está segmentado com base no produto, tecnologia, prescrição, aplicação, utilizador final e canal de distribuição. O crescimento entre estes segmentos irá ajudá-lo a analisar os escassos segmentos de crescimento nas indústrias e fornecer aos utilizadores uma valiosa visão geral do mercado e insights de mercado para os ajudar a tomar decisões estratégicas para identificar as principais aplicações do mercado.
Produto
- Monitorização de Glicose
- Tiras
- Metros
- Lancetas
- Teste cardiometabólico
- Teste de marcador cardíaco
- hsTnl
- BNP
- D-dímero
- CK-MB
- Mioglobina
- Outros
- Teste de gases sanguíneos/eletrólitos
- Teste HBA1C
- Testes de doenças infeciosas
- Teste de gripe
- Teste de VIH
- Teste de hepatite C
- Teste de doenças sexualmente transmissíveis (DST)
- Teste de infeção associada à assistência à saúde (HAI)
- Teste de infeção respiratória
- Testes de doenças tropicais
- Testes para outras doenças infeciosas
- Teste de coagulação
- Teste PT/INR
- Teste do tempo de coagulação ativado (ACT/APTT)
- Testes de gravidez e fertilidade
- Teste de gravidez
- Teste de fertilidade
- Teste de marcadores tumorais/cancro
- Teste de urinálise
- Teste de colesterol
- Testes hematológicos
- Testes de drogas de abuso
- Teste oculto fecal
- Outros
Tecnologia
- Ensaios de fluxo lateral
- Varetas
- Microfluídica
- Diagnóstico molecular
- Imunoensaios
- Ensaios de aglutinação
- Fluxo
- Fase sólida
- Biossensores
Prescrição
- Teste OTC
- Testes baseados na prescrição
Aplicação
- Teste cardiometabólico
- Testes de doenças infeciosas
- Testes de nefrologia
- Teste de drogas de abuso (DoA)
- Teste de glicemia
- Teste de gravidez
- Teste de biomarcadores de cancro
- Outras aplicações
Utilizador final
- Hospitais
- Centros de diagnóstico
- Laboratórios de investigação
- Configurações de atendimento domiciliário
- Outros
Canal de distribuição
- Concurso direto
- Farmácias de Retalho
Análise/perspetivas regionais do mercado de testes no ponto de atendimento (POCT)
O mercado de testes no ponto de atendimento (POCT) é analisado e os insights e tendências do tamanho do mercado são fornecidos por país, produto, tecnologia, prescrição, utilizador final de aplicação e canal de distribuição, conforme mencionado acima.
Os países abrangidos no relatório de mercado de testes no local de atendimento (POCT) são a China, Japão, Índia, Coreia do Sul, Singapura, Malásia, Austrália, Tailândia, Indonésia, Filipinas, Resto da Ásia-Pacífico (APAC) na Ásia- Pacífico (APAC).
Espera-se que a China domine o mercado porque os produtos de teste no local de atendimento (POCT) na China têm um enorme espaço de aplicação nas áreas de operação hospitalar, departamento de emergência, cuidados intensivos, prevenção e controlo de doenças crónicas, emergências de saúde pública, condado- construção de instituições médicas de alto nível e novos cuidados médicos de apoio rural.
O Japão dominará o mercado devido a um número crescente de pessoas que sofrem de VIH e outras doenças, o que resultará numa elevada taxa de aprovação de dispositivos de teste no local de atendimento no país. A Índia é o país dominante devido à elevada prevalência de doenças entre o seu povo.
A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas da Ásia-Pacífico e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas domésticas e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.
Crescimento da infraestrutura de saúde Base instalada e penetração de novas tecnologias
O mercado de testes no local de atendimento (POCT) também fornece análises de mercado detalhadas para o crescimento de cada país em despesas de saúde para equipamentos de capital, base instalada de diferentes tipos de produtos para o mercado de testes no local de atendimento (POCT ), impacto da tecnologia utilizando curvas de linha de vida e mudanças nos cenários regulamentares de saúde e o seu impacto no mercado de testes no local de prestação de cuidados (POCT). Os dados estão disponíveis para o período histórico 2010-2020.
Análise do cenário competitivo e da quota de mercado dos testes no local de atendimento (POCT)
O panorama competitivo do mercado de testes no local de atendimento (POCT) fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença na Ásia-Pacífico, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa, lançamento de produtos, largura e amplitude do produto , dominância da aplicação. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado de testes no local de atendimento (POCT).
Alguns dos principais players que trabalham no mercado de testes no local de atendimento (POCT) são:
- Abbott (EUA)
- F. Hoffmann-La Roche Ltd (Suíça)
- BD (EUA)
- Siemens Healthcare Private Limited (Alemanha)
- (EUA)
- Danaher (EUA)
- Diagnóstico Sekisui (EUA)
- Trinity Biotech (Irlanda)
- bioMérieux (França)
- Diagnóstico EKF (Alemanha)
- (China)
- Laboratório de Instrumentação (EUA)
- (EUA)
- Diagnóstico PTS (EUA)
- Nova Biomedical (EUA)
- Chembio Diagnostics, Inc.
- Quidel Corporation (EUA)
- Sienco, Inc (EUA)
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 DISTRIBUTION CHANNEL OF ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 LIST OF DISTRIBUTORS IN ASIA PACIFIC REGION FOR POINT-OF-CARE-TESTING MARKET
5 COVID-19 IMPACT ON ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET
5.1 IMPACT ON DEMAND
5.2 PRICE IMPACT
5.3 IMPACT ON SUPPLY CHAIN
5.4 STRATEGIC DECISIONS FOR MANUFACTURERS
5.5 CONCLUSION
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
6.1.2 IMPROVING DIAGNOSIS SEEKING RATE
6.1.3 GROWING POPULARITY OF WEARABLE OR PORTABLE GLUCOSE MONITORING DEVICES
6.1.4 RISING PREFERENCE FOR HOMECARE TESTING
6.2 RESTRAINTS
6.2.1 PRODUCT RECALLS
6.2.2 HIGH COSTS OF PRODUCTS
6.2.3 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS
6.3 OPPORTUNITIES
6.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
6.3.2 RISING AWARENESS AND GOVERNMENT FUNDING
6.3.3 TECHNOLOGICAL ADVANCEMENTS IN POINT-OF-CARE TESTING DEVICES
6.4 CHALLENGE
6.4.1 LACK OF ALIGNMENT WITH TEST RESULTS OBTAINED FROM LABORATORIES
7 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.1.1 GLUCOSE MONITORING PRODUCTS
7.1.1.1 STRIPS
7.1.1.2 METERS
7.1.1.3 LANCETS & LANCING DEVICES
7.1.2 INFECTIOUS DISEASE TESTING PRODUCTS
7.1.2.1 INFLUENZA
7.1.2.2 HIV TESTING PRODUCTS
7.1.2.3 HEPATITIS C
7.1.2.4 SEXUALLY TRANSMITTED DISEASE (STD)
7.1.2.5 HEALTHCARE-ASSOCIATED INFECTION (HAI)
7.1.2.6 RESPIRATORY INFECTION
7.1.2.7 TROPICAL DISEASE
7.1.2.8 OTHER INFECTIOUS DISEASE
7.1.3 CARDIOMETABOLIC TESTING PRODUCTS
7.1.3.1 BLOOD GAS/ELECTROLYTES
7.1.3.2 HBA1C TESTING PRODUCTS
7.1.3.3 CARDIAC MARKER TESTING PRODUCTS
7.1.3.4 LIPID TESTING KITS
7.1.4 PREGNANCY AND FERTILITY TESTING PRODUCTS
7.1.4.1 PREGNANCY TESTING PRODUCTS
7.1.4.2 FERTILITY TESTING PRODUCTS
7.1.5 HEMATOLOGY TESTING PRODUCTS
7.1.5.1 BLOOD ANAYZER
7.1.5.2 REAGENTS AND KITS
7.1.6 RAPID COAGULATION TESTING
7.1.6.1 COAGULATION ANALYZER
7.1.6.2 TESTING KIT
7.2 DRUGS-OF-ABUSE TESTING PRODUCTS
7.3 URINALYSIS TESTING PRODUCTS
7.4 CHOLESTEROL TESTING PRODUCTS
7.5 TUMOR/CANCER MARKER TESTING PRODUCTS
7.6 FECAL OCCULT TESTING PRODUCTS
7.7 OTHER POC PRODUCTS
8 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 BLOOD GLUCOSE
8.3 CARDIAC MONITORING LUCOSE
8.4 HAEMATOLOGY
8.4.1 WBC COUNT
8.4.2 DNA SEQUENCING REAGENTS & KITS
8.5 COAGULATION
8.6 WHOLE BLOOD ANALYSIS
8.6.1 BLOOD GASES
8.6.2 ELECTROLYTES & METABOLITES
8.7 VITAL SIGN MONITORING
8.7.1 HEART RATE
8.7.2 BLOOD PRESSURE
8.7.3 RESPIRATORY RATE 59.37
8.7.4 TEMPERATURE
8.8 NON- INVASIVE SPO2 MONITORING
8.9 NON- INVASIVE PCO2 MONITORING
8.1 BLOOD TRANSFUSION
9 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PLATFORM
9.1 OVERVIEW
9.2 LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS
9.3 DIPSTICKS
9.4 MOLECULAR DIAGNOSTICS ENOME SEQUENCING
9.5 IMMUNOASSAYS
9.6 MICROFLUIDICS
10 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE
10.1 OVERVIEW
10.2 OTC TESTING
10.3 PRESCRIPTION-BASED TESTING
11 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE
11.1 OVERVIEW
11.2 IMMUNOASSAYS
11.3 NUCLEIC ACID AMPLIFICATION TESTING
11.4 HAEMATOLOGY
11.5 CLINICAL CHEMISTRY ASSAYS
11.6 CELL-BASED ASSAYS
12 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY END USER
12.1 OVERVIEW
12.2 CLINICS
12.3 HOME CARE
12.4 HOSPITALS
12.5 LABORATORIES
12.6 AMBULATORY SURGICAN CENTERS
12.7 OTHERS
13 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAIL PHARMACIES
14 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET BY COUNTRY
14.1 OVERVIEW
14.1.1 CHINA
14.1.2 JAPAN
14.1.3 INDIA
14.1.4 SOUTH KOREA
14.1.5 AUSTRALIA
14.1.6 SINGAPORE
14.1.7 MALAYSIA
14.1.8 THAILAND
14.1.9 INDONESIA
14.1.10 PHILIPPINES
14.1.11 REST OF ASIA-PACIFIC
15 ASIA-PACIFIC POINT-OF-CARE (POCT) MARKET, COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 F.HOFFMANN-LA ROCHE LTD
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENT
17.2 SIEMENS HEALTHCARE PRIVATE LIMITED
17.2.1 COMPANY SNAPSHOT
17.2.1 PRODUCT PORTFOLIO
17.2.2 RECENT DEVELOPMENTS
17.3 BD
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENTS
17.4 DANAHER
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENTS
17.5 BIOMÉRIEUX SA
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENTS
17.6 ABBOTT
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENTS
17.7 ACCUBIOTECH CO.,LTD.
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENTS
17.8 BECKMAN COULTER,INC.
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENTS
17.9 BIO-RAD LABORATORIES, INC.
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENTS
17.1 CHEMBIO DIAGNOSTICS SYSTEMS,INC.
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENTS
17.11 EKF DIAGNOSTICS
17.11.1 COMPANY SNAPSHOT
17.11.2 REVENUE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENTS
17.12 INSTRUMENTATION LABORATORY
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 NOVA BIOMEDICAL
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENTS
17.14 PTS DIAGNOSTICS
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 QUIDEL CORPORATION
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENTS
17.16 SEKISUI DIAGNOSTICS
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENTS
17.17 SIENCO,INC.
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 TRINITY BIOTECH
17.18.1 COMPANY SNAPSHOT
17.18.2 REVENUE ANALYSIS
17.18.3 PRODUCT PORTFOLIO
17.18.4 RECENT DEVELOPMENTS
18 QUESTIONNAIRE
19 RELATED REPORTS
Lista de Tabela
LIST OF TABLES
TABLE 1 DIFFERENT ASSOCIATIONS FOR DIAGNOSTICS
TABLE 2 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 3 ASIA-PACIFIC GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)
TABLE 4 ASIA-PACIFIC INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)
TABLE 5 ASIA-PACIFIC CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)
TABLE 6 ASIA-PACIFIC PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 7 ASIA-PACIFIC HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 8 ASIA-PACIFIC RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 9 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT & SERVICE, 2018-2027 (USD MILLION)
TABLE 10 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT & SERVICE, 2018-2027 (USD MILLION)
TABLE 11 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT & SERVICE, 2018-2027 (USD MILLION)
TABLE 12 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT & SERVICE, 2018-2027 (USD MILLION)
TABLE 13 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY TECHNOLOGIES, 2018-2027 (USD MILLION)
TABLE 14 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)
TABLE 15 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 16 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 17 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 18 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 19 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 20 ASIA-PACIFIC GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)
TABLE 21 ASIA-PACIFIC CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 22 ASIA-PACIFIC INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 23 ASIA-PACIFIC PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 24 ASIA-PACIFIC CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 25 ASIA-PACIFIC HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 26 ASIA-PACIFIC RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 27 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 28 ASIA-PACIFIC HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 29 ASIA-PACIFIC WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)
TABLE 30 ASIA-PACIFIC VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)
TABLE 31 ASIA-PACIFIC POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)
TABLE 32 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)
TABLE 33 ASIA-PACIFIC POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)
TABLE 34 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)
TABLE 35 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
TABLE 36 CHINA POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 37 CHINA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)
TABLE 38 CHINA CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 39 CHINA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 40 CHINA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 41 CHINA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 42 CHINA HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 43 CHINA RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 44 CHINA POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 45 CHINA HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 46 CHINA WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)
TABLE 47 CHINA VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)
TABLE 48 CHINA POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)
TABLE 49 CHINA POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)
TABLE 50 CHINA POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)
TABLE 51 CHINA POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)
TABLE 52 CHINA POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
TABLE 53 JAPAN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 54 JAPAN GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)
TABLE 55 JAPAN CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 56 JAPAN INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 57 JAPAN PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 58 JAPAN CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 59 JAPAN HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 60 JAPAN RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 61 JAPAN POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 62 JAPAN HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 63 JAPAN WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)
TABLE 64 JAPAN VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)
TABLE 65 JAPAN POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)
TABLE 66 JAPAN POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)
TABLE 67 JAPAN POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)
TABLE 68 JAPAN POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)
TABLE 69 JAPAN POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
TABLE 70 INDIA POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 71 INDIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)
TABLE 72 INDIA CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 73 INDIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 74 INDIA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 75 INDIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 76 INDIA HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 77 INDIA RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 78 INDIA POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 79 INDIA HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 80 INDIA WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)
TABLE 81 INDIA VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)
TABLE 82 INDIA POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)
TABLE 83 INDIA POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)
TABLE 84 INDIA POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)
TABLE 85 INDIA POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)
TABLE 86 INDIA POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
TABLE 87 SOUTH KOREA POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 88 SOUTH KOREA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)
TABLE 89 SOUTH KOREA CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 90 SOUTH KOREA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 91 SOUTH KOREA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 92 SOUTH KOREA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 93 SOUTH KOREA HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 94 SOUTH KOREA RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 95 SOUTH KOREA POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 96 SOUTH KOREA HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 97 SOUTH KOREA WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)
TABLE 98 SOUTH KOREA VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)
TABLE 99 SOUTH KOREA POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)
TABLE 100 SOUTH KOREA POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)
TABLE 101 SOUTH KOREA POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)
TABLE 102 SOUTH KOREA POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)
TABLE 103 SOUTH KOREA POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
TABLE 104 AUSTRALIA POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 105 GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)
TABLE 106 AUSTRALIA CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 107 AUSTRALIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 108 AUSTRALIA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 109 AUSTRALIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 110 AUSTRALIA HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 111 AUSTRALIA RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 112 AUSTRALIA POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 113 AUSTRALIA HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 114 AUSTRALIA WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)
TABLE 115 AUSTRALIA VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)
TABLE 116 AUSTRALIA POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)
TABLE 117 AUSTRALIA POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)
TABLE 118 AUSTRALIA POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)
TABLE 119 AUSTRALIA POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)
TABLE 120 AUSTRALIA POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
TABLE 121 SINGAPORE POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 122 SINGAPORE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)
TABLE 123 SINGAPORE CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 124 SINGAPORE INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 125 SINGAPORE PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 126 SINGAPORE CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 127 SINGAPORE HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 128 SINGAPORE RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 129 SINGAPORE POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 130 SINGAPORE HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 131 SINGAPORE WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)
TABLE 132 SINGAPORE VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)
TABLE 133 SINGAPORE POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)
TABLE 134 SINGAPORE POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)
TABLE 135 SINGAPORE POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)
TABLE 136 SINGAPORE POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)
TABLE 137 SINGAPORE POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
TABLE 138 MALAYSIA POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 139 MALAYSIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)
TABLE 140 MALAYSIA CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 141 MALAYSIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 142 MALAYSIA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 143 MALAYSIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 144 MALAYSIA HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 145 MALAYSIA RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 146 MALAYSIA POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 147 MALAYSIA HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 148 MALAYSIA WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)
TABLE 149 MALAYSIA VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)
TABLE 150 MALAYSIA POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)
TABLE 151 MALAYSIA POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)
TABLE 152 MALAYSIA POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)
TABLE 153 MALAYSIA POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)
TABLE 154 MALAYSIA POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
TABLE 155 THAILAND POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 156 THAILAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)
TABLE 157 THAILAND CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 158 THAILAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 159 THAILAND PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 160 THAILAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 161 THAILAND HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 162 THAILAND RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 163 THAILAND POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 164 THAILAND HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 165 THAILAND WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)
TABLE 166 THAILAND VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)
TABLE 167 THAILAND POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)
TABLE 168 THAILAND POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)
TABLE 169 THAILAND POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)
TABLE 170 THAILAND POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)
TABLE 171 THAILAND POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
TABLE 172 INDONESIA POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 173 INDONESIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)
TABLE 174 INDONESIA CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 175 INDONESIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 176 INDONESIA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 177 INDONESIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 178 INDONESIA HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 179 INDONESIA RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 180 INDONESIA POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 181 INDONESIA HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 182 NDONESIA WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)
TABLE 183 INDONESIA VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)
TABLE 184 INDONESIA POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)
TABLE 185 INDONESIA POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)
TABLE 186 INDONESIA POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)
TABLE 187 INDONESIA POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)
TABLE 188 INDONESIA POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
TABLE 189 PHILIPPINES POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 190 PHILIPPINES GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027, (USD MILLION)
TABLE 191 PHILIPPINES CARDIO METABOLIC TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 192 PHILIPPINES INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 193 PHILIPPINES PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 194 PHILIPPINES CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 195 PHILIPPINES HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 196 PHILIPPINES RAPID COAGULATION TESTING PRODUCTS IN POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
TABLE 197 PHILIPPINES POINT-OF-CARE TESTING (POCT) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 198 PHILIPPINES HAEMATOLOGY IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 199 PHILIPPINES WHOLE BLOOD ANALYSIS IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE , 2018-2027 (USD MILLION)
TABLE 200 PHILIPPINES VITAL SIGN MONITORING IN POINT-OF-CARE TESTING (POCT) MARKET, BY TYPE 2018-2027 (USD MILLION)
TABLE 201 PHILIPPINES POINT OF CARE TESTING MARKET, BY PLATFORM 2018-2027 (USD MILLION)
TABLE 202 PHILIPPINES POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE 2018-2027 (USD MILLION)
TABLE 203 PHILIPPINES POINT OF CARE TESTING POINT-OF-CARE TESTING (POCT) MARKET, BY TESTING TYPE 2018-2027 (USD MILLION)
TABLE 204 PHILIPPINES POINT-OF-CARE TESTING (POCT) MARKET, BY END USER 2018-2027 (USD MILLION)
TABLE 205 PHILIPPINES POINT-OF-CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
TABLE 206 REST OF ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT , 2018-2027 (USD MILLION)
Lista de Figura
LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET : REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: MULTIVARIATE MODELLING
FIGURE 8 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: SEGMENTATION
FIGURE 11 INCREASING PREVALENCE OF CHRONIC DISEASES AND IMPROVING DIAGNOSIS SEEKING RATE ARE EXPECTED TO DRIVE THE ASIA-PACIFIC POINT-OF-CARE (POCT) TESTING MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
FIGURE 12 GLUCOSE MONITORING PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC POINT-OFCARE (POCT) TESTING MARKET IN 2020 & 2027
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET
FIGURE 14 EPIDEMIOLOGY OF CHRONIC CONDITIONS (1990-2015)
FIGURE 15 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY PRODUCT TYPE, 2019
FIGURE 16 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY PRODUCT TYPE, 2019-2027 (USD MILLION)
FIGURE 17 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY PRODUCT TYPE, CAGR (2020-2027)
FIGURE 18 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 19 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2019
FIGURE 20 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2019-2027 (USD MILLION)
FIGURE 21 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, CAGR (2020-2027)
FIGURE 22 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 23 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2019
FIGURE 24 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2019-2027 (USD MILLION)
FIGURE 25 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, CAGR (2020-2027)
FIGURE 26 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 27 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE , 2019
FIGURE 28 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE , 2019-2027 (USD MILLION)
FIGURE 29 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE , CAGR (2020-2027)
FIGURE 30 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE , LIFELINE CURVE
FIGURE 31 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY TESTING TYPE, 2019
FIGURE 32 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY TESTING TYPE, 2019-2027 (USD MILLION)
FIGURE 33 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY TESTING TYPE, CAGR (2020-2027)
FIGURE 34 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY TESTING TYPE, LIFELINE CURVE
FIGURE 35 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2019
FIGURE 36 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2019-2027 (USD MILLION)
FIGURE 37 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, CAGR (2020-2027)
FIGURE 38 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, LIFELINE CURVE
FIGURE 39 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2019
FIGURE 40 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
FIGURE 41 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2027)
FIGURE 42 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 43 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: SNAPSHOT (2019)
FIGURE 44 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY COUNTRY (2019)
FIGURE 45 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY COUNTRY (2020 & 2027)
FIGURE 46 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY COUNTRY (2019 & 2027)
FIGURE 47 ASIA-PACIFIC POINT-OF-CARE TESTING (POCT) MARKET: BY TESTING TYPE (2020-2027)
FIGURE 48 ASIA-PACIFIC POINT-OF-CARE (POCT) MARKET: COMPANY SHARE 2019 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.